This bill directs New Jersey's Department of Children and Families to improve access to mental health care for children and their families. It requires the department to expand services through the New Jersey Pediatric Psychiatry Collaborative, which includes adding telehealth options, providing real-time psychiatric support to pediatric doctors, and offering better training and referral systems. The legislation also mandates greater transparency by setting specific performance goals for service providers, making contract results public, and launching a public awareness campaign to help families find care. Additionally, the bill establishes a new requirement for hospitals and clinics to report standardized data on how often children seek psychiatric or behavioral health services.
This bill allows New Jersey healthcare providers to prescribe Schedule II controlled substances, such as certain pain medications, through telemedicine without requiring an in-person examination. It permits these prescriptions based on a remote provider-patient relationship, provided the provider has reviewed the patient's medical records and determined they can meet the standard of care remotely. The legislation also mandates that providers disclose their credentials, offer patients the option to see a physician specifically, and ensure proper follow-up care is arranged. By amending existing state laws, the bill expands access to specific controlled medications for patients using virtual healthcare services while maintaining regulatory oversight.
This bill requires healthcare platforms in New Jersey to advise and consult with consumers regarding the therapeutic values, hazards, and uses of drugs, biologicals, and devices they send. The law mandates that these platforms provide this information using electronic methods such as email, text messaging, or video calls. It directly affects online services that allow members to obtain discounts on medications or access telemedicine services. The legislation clarifies that these platforms must follow existing pharmacy practice standards when communicating with users about their prescriptions and medical devices.
This bill updates New Jersey laws to clarify how telehealth and telemedicine can be used for prescribing certain Schedule II drugs to treat adult attention-deficit/hyperactivity disorder. It allows licensed healthcare providers to remotely prescribe these medications if they have established a proper relationship with the patient and can meet the same standard of care as an in-person visit. The legislation also ensures patients are informed about whether their provider is a physician, receive clear contact information, and have their medical records properly updated and shared with other doctors. Additionally, it requires providers to assist patients in finding in-person care or primary care providers when necessary.
This bill allows doctors in New Jersey to prescribe certain controlled substances, such as some pain medications, via telemedicine without requiring an in-person visit. It permits providers to use asynchronous methods, like reviewing medical records before a call, as long as they can meet the same standard of care as an in-person appointment. The legislation also mandates that patients be informed if their provider is not a physician and ensures that all telehealth interactions are properly documented and integrated into the patient's medical record.
This bill allows New Jersey to join the Athletic Trainer Compact, a national agreement that lets licensed athletic trainers practice in other member states without needing separate licenses for each location. Under the new rules, qualified trainers from other states can provide services in New Jersey through a streamlined "compact privilege" as long as they meet uniform standards and agree to be regulated by the state where the patient is located. The legislation also includes provisions to support military families, facilitate telehealth services, and improve the sharing of disciplinary information among member states to protect public safety.
This bill allows doctors in New Jersey to prescribe Schedule II controlled substances, such as certain pain medications, through telemedicine and telehealth without requiring an in-person visit. It permits providers to use digital tools like video calls or asynchronous messaging to evaluate patients, provided they have already reviewed the patient's medical records and determined that remote care meets the same standard of care as an in-person appointment. The legislation also mandates that patients be informed if their provider is not a physician and must be given the option to request a consultation with a doctor, while ensuring all telehealth interactions are properly documented and referrals for in-person care are made when necessary.
This bill requires New Jersey Medicaid to cover remote stress tests for pregnant women. It amends existing Medicaid regulations to explicitly include this specific diagnostic service under the program's authorized benefits. The change directly affects pregnant women enrolled in Medicaid and the healthcare providers who administer these tests. The legislation does not alter other Medicaid services or introduce new requirements beyond this specific coverage addition.
This bill permanently extends pay parity for telemedicine and telehealth services in New Jersey, requiring health insurance carriers to reimburse providers at the same rates as in-person care. It directly affects insurance companies, healthcare providers, and patients by mandating that out-of-pocket costs like deductibles and copayments for virtual visits cannot exceed those for in-person appointments. The legislation also prohibits insurers from restricting telehealth platforms, limiting service locations, or denying coverage for routine remote monitoring if the same care would be covered in person. Additionally, carriers must continue to allow patients to choose between in-person and virtual care rather than forcing telehealth as a substitute.
This bill allows health care professionals licensed in New Jersey to provide telemedicine and telehealth services to patients in New Jersey, even if the provider is located outside the state. It requires providers to maintain valid NJ licensure, follow the same standard of care as in-person visits, and use real-time communication for most services (with limited exceptions for store-and-forward technology). The law specifically permits prescriptions for Schedule II controlled substances only after an initial in-person exam, except for minors with parental consent. It also mandates that providers share patient records with the patient's primary care provider upon request and ensures mental health screenings can use telehealth without additional authorization. The bill directly affects out-of-state health care providers seeking to serve NJ patients and NJ patients seeking remote care options.
